Skip to main content

Table 3 Summary of CUA of CKD patients undergoing kidney transplant included in the review

From: Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review

Study Country Year Perspective Discount rate (%) Time horizon Model structure
CUA of transplanting infectious kidneys (n = 03)
 Kadatz et al. [26] Canada 2018 Health- care payer and Societal 1.5 10 years Markov decision model
 Kiberd et al. [27] Canada 1994 Not explicitly stated (Health- care payer costs identified) 5 20 years Not explicitly stated (Markov decision model identified)
 Schweitzer et al. [34] USA 2007 Societal perspective 3 20 years Markov decision model
CUA of kidney allocation policies (n = 09)
 Axelrod et al. [21] USA 2018 Health- care payer 3 10 years Discreet Event Simulation
 Smith et al. [35] USA 2015 Health- care payer 3 20 years Markov decision model
 Mutinga et al. [31] USA 2005 Not explicitly stated (Health- care payer costs identified) 5 20 years Markov decision model
 Schnitzler et al. [33] USA 2003 Health- care payer 5 20 years Markov decision model
 Bavanandan et al. [23] Malaysia 2015 Health- care payer 3 Life time Not explicitly stated (Markov decision model identified)
 Snyder et al. [36] USA 2010 Societal perspective 3 10 years Markov decision model
 Cavallo et al. [24] Italy 2014 Health- care payer 3.5 05 years Markov decision model
 Barnieh et al. [22] Canada 2013 Health- care payer 5 Life time Markov decision model
 Matas et al. [29] USA 2003 Societal perspective 5 20 years Markov decision model
CUA of technology used in KT (n = 04)
 Nguyen et al. [32] Australia 2015 Health- care payer 5 20 years Markov decision model
 McLaughlin et al. [30] Canada 2006 Health- care payer 5 25 years Markov decision model
 Groen et al. [25] Europe 2012 Health- care payer 4 10 years Markov decision model
 Liem et al. [28] Netherlands 2003 Societal perspective 3 Life time Markov decision model
  1. HCV NAT Hepatitis C nucleic acid test, CDC IRDs Centers for Disease Control classified increased risk donors, KDPI Kidney Donor Profile Index, ECD expanded criteria donor, SD standard donor, LKT living kidney transplant, DKT deceased kidney transplant, DBD donation after brain death,DCD donation after cardiac death, CDC complement-dependent cytotoxicity